Form 4: Biodesix CFO Robin Harper Cowie Reports Stock Transactions
SEC Form 4 Filing
Robin Harper Cowie, CFO, Secretary, and Treasurer of Biodesix Inc., reports transactions involving common stock and derivative securities.
Summary
- Robin Harper Cowie, the CFO, Secretary, and Treasurer of Biodesix Inc., filed a Form 4 detailing changes in beneficial ownership.
- On May 21, 2024, Cowie exercised stock options to acquire 4,209 shares of common stock at a price of $0.42 per share.
- On May 23, 2024, Cowie converted Series A Non-Voting Convertible Preferred Stock into 13,080 shares of common stock.
- Following these transactions, Cowie directly owns 188,969 shares of Biodesix Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is common in the biotech industry.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increase in the number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| January 1, 2023 | Stock options vested in full |
| April 3, 2028 | Expiration date of stock options |
| May 21, 2024 | Stockholder approval of preferred stock conversion; exercise of stock options |
| May 23, 2024 | Conversion of Series A Non-Voting Convertible Preferred Stock into common stock |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.